Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)

M Mahboubi-Rabbani, AH Abdolghaffari… - Expert Opinion on …, 2024 - Taylor & Francis
potential to greatly increase the effectiveness of chemotherapy. Our extensive understanding
of selective COX-2 inhibitor … the widespread administration of selective COX-2 inhibitors as …

Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing

AA El-Malah, MM Gineinah, PK Deb, AN Khayyat… - Pharmaceuticals, 2022 - mdpi.com
… claimed lower potential of serious … treatment of corticosteroids, while the other (ie, COX-2)
is induced by the inflammatory stimuli or cytokines that can be inhibited by the administration of …

[HTML][HTML] COX-2 as a potential biomarker and therapeutic target in melanoma

DV Tudor, I Bâldea, M Lupu, T Kacso… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
… could be a suitable choice as adjuvants in the therapeutic management of … COX-2 inhibitors
efficacy used alone or as part of combination therapy in melanoma. COX-2 inhibitors tested …

[HTML][HTML] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement

S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
… In addition, such a combination can reduce toxicity and chemoresistance and enhance
radiosensitivity, although COX-2 inhibitors-related cardiotoxicity may potentially affect its use. …

NSAIDs: Old acquaintance in the pipeline for cancer treatment and prevention─ Structural modulation, mechanisms of action, and bright future

S Ramos-Inza, AC Ruberte, C Sanmartin… - Journal of Medicinal …, 2021 - ACS Publications
COX-2 enzyme and production of immunosuppressive prostaglandin E2 (PGE2). This fact
confirmed COX-2 inhibition … the potential benefits of NSAIDs in the prevention and treatment of …

New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation

EM Ahmed, MSA Hassan, AA El-Malah, AE Kassab - Bioorganic chemistry, 2020 - Elsevier
… towards COX-2 inhibition compared to indomethacin. Compounds 3d, 3g and 6a exhibited
significantly increased potency towards COX-2 … Furthermore, the selective COX-2 inhibitor 3g …

NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase

OR Kolawole, K Kashfi - International journal of molecular sciences, 2022 - mdpi.com
… trials with COX-2 inhibitors for cancer prevention or treatment. … and selective COX-2 inhibitors
(COXIBs) on targets beyond … Therefore, there is a potential role for NSAIDs via activation to …

Gut-restricted selective cyclooxygenase-2 (COX-2) inhibitors for chemoprevention of colorectal cancer

Z Zhang, A Ghosh, PJ Connolly, P King… - Journal of Medicinal …, 2021 - ACS Publications
potential). Celecoxib (1, PDB ID: 3LN1) is superimposed as purple sticks for reference. …
(as 18 F-FDG) uptake from short-term treatment (2 weeks) as an indirect PD surrogate and …

Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer

D Pu, L Yin, L Huang, C Qin, Y Zhou, Q Wu, Y Li… - … in oncology, 2021 - frontiersin.org
… This review summarizes the roles of COX-2 in the resistance of ICIs and proposes a … COX-2
inhibitors really useful in cancer treatment? COX-2 expression level, metabolites or COX-2-…

Cyclooxygenase-2 (COX-2) as a target of anticancer agents: A review of novel synthesized scaffolds having anticancer and COX-2 inhibitory potentialities

NUA Mohsin, S Aslam, M Ahmad, M Irfan… - Pharmaceuticals, 2022 - mdpi.com
management of cancer-related pain and inflammation. The … of new COX-2 inhibitors due
to their unique role in cancer … radical scavenging potential compared to compound 45 [58]. …